Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1. | Bioorg Med Chem Lett;21(5): 1394-8, 2011 Mar 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Synthesis and evaluation of 2-phenyl-1,4-butanediamine-based CCR5 antagonists for the treatment of HIV-1.

Tallant, Matthew D; Duan, Maosheng; Freeman, George A; Ferris, Robert G; Edelstein, Mark P; Kazmierski, Wieslaw M; Wheelan, Pat J.

Affiliation

Tallant MD; Department of Chemistry, GlaxoSmithKline, Research Triangle Park, NC 27709, USA. matthew.d.tallant@gsk.com

Bioorg Med Chem Lett ; 21(5): 1394-8, 2011 Mar 01.

Article in En | MEDLINE | ID: mdl-21292480

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Putrescine / Anti-HIV Agents / CCR5 Receptor Antagonists Limits: Animals Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2011 Document type: Article Affiliation country: Estados Unidos

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Putrescine / Anti-HIV Agents / CCR5 Receptor Antagonists Limits: Animals Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2011 Document type: Article Affiliation country: Estados Unidos